Latest News about IPHA
Recent news which mentions IPHA
From Benzinga
 
   Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
   
  
  
  September 19, 2022
  From Benzinga
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  September 19, 2022
  From Benzinga
 
   Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
   
  
  
  September 19, 2022
  From InvestorPlace
 
   Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket
   
  
  
  September 19, 2022
  From Benzinga
 
   Earnings Scheduled For September 15, 2022
   
  
  
  September 15, 2022
  From Benzinga
 From Benzinga
 
   This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
   
  
  
  August 01, 2022
  From Benzinga
 
   Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
   
  
  
  August 01, 2022
  From Benzinga
 From Benzinga
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  August 01, 2022
  From Benzinga
 From InvestorPlace
 
   Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket
   
  
  
  August 01, 2022
  From Benzinga
 
   67 Biggest Movers From Yesterday
   
  
  
  June 22, 2022
  From Benzinga
 
   89 Biggest Movers From Friday
   
  
  
  June 21, 2022
  From Benzinga
 
   70 Biggest Movers From Friday
   
  
  
  May 02, 2022
  From Benzinga
 
   48 Stocks Moving In Friday's Mid-Day Session
   
  
  
  April 29, 2022
  From Benzinga
 From Benzinga
 
   28 Stocks Moving in Friday's Pre-Market Session
   
  
  
  April 29, 2022
  From Benzinga
 
   Earnings Scheduled For March 24, 2022
   
  
  
  March 24, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   20 Stocks Moving in Tuesday's Pre-Market Session
   
  
  
  January 25, 2022
  From Benzinga
 
   The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
   
  
  
  January 05, 2022
  From Benzinga
 
   18 Stocks Moving in Monday's Pre-Market Session
   
  
  
  January 03, 2022
  From Benzinga
 
   Innate Pharma Says Chemo-Free Monalizumab Triplet Therapy Shows Preliminary Anti-Cancer Activity
   
  
  
  December 09, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.